We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...
The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...
The global medication adherence market is experiencing rapid growth, with projections indicating a robust CAGR of 11.1% during the forecast period from 2022 to 2028. This growth is primarily driven by ...
12h
Asianet Newsable on MSNRegencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last WeekHong Kong-based Regencell focuses on traditional Chinese medicine for neurocognitive disorders, particularly ADHD and autism.
The global neurodegenerative disease market is on a trajectory of significant expansion, with its valuation expected to surge from USD 52.08 billion in 2024 to USD 102.4 billion by 2034, reflecting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results